from Stem Cells for Therapy and Drug Safety Evaluation 14.01.2021 Dr. Jessica Rademacher MHH, Klinik für Pneumologie Antibiotic Stewardship 09.07.2020 Dr. Meik Kunz, Erlangen Institut für Medizininformatik [...] Erlangen-Nürnberg Integrative bioinformatics analysis and modeling of human physiology 18.06.2020 Prof. Christian Wahl-Schott, MHH (Institut für Neurophysiologie) Second messenger-activated cation channels: [...] Filippo Perbellini, MHH/Imperial College London Living myocardial slices: a novel multicellular model for cardiac translational research 28.11.2019 Dr. Monika Bokori-Brown, Exeter Unlocking the molecular secrets

2022 Apr 6.PMID: 35390273 PubMed Shcherbata HR. The Russian invasion of Ukraine: a humanitarian tragedy and a tragedy for science EMBO Rep. 2022 May 4;23(5):e55164. doi: 10.15252/embr.202255164. PubMed Karki [...] Marrone AK, Rishko VM, Magliarelli Hde F, Shcherbata HR: Stress and muscular dystrophy: a genetic screen for dystroglycan and dystrophin interactors in Drosophila identifies cellular stress response [...] redundant for Dystroglycan function . BMC Dev Biol 2009, 9 :18. (PubMed) Qi J, Yu JY, Shcherbata HR, Mathieu J, Wang AJ, Seal S, Zhou W, Stadler BM, Bourgin D, Wang L et al : microRNAs regulate human embryonic

compartment as resilient markers for safe kidney transplantation Nick Heise, GERMANY, Heise.Nick @ mh-hannover.de Supervisor: Prof. Dr. Christian Bär / Dr. Jeannine Höpfner (Institute of Molecular and Translational [...] tissue-specific AAV vectors for neuromuscular gene therapies Subham Rana , INDIA, Subham.Rana @ mh-hannover.de Supervisor: Prof. Dr. Christian Bär / Prof. Dr. Thomas Thum (Institute of Molecular and Translational [...] Wilson.Agyapong @ mh-hannover.de Supervisor: Dr. Natalie Weber, PhD / Prof. Dr. Dr. Thomas Thum (Institute of Molecular and Translational Therapeutic Strategies IMTTS and Fraunhofer ITEM) Project: Investigation

Klasse II Myosinen . Dr. Mamta-Amruta-Nayak , Institut für Molekular- und Zellphysiologie. Kinetische Untersuchungen der Aktivität von Myofibrillen aus humanen Biopsien von Kardiomyopathie-Patienten . Prof [...] Bogdan Iorga , Institut für Molekular- und Zellphysiologie. Validation of the anti-cancer activity of the myosin-9 inhibitor adhibin in the mouse tumor model . Prof. Dr. Detlef Neumann , Institut für Pharmakologie [...] Knölker , Institute für Organische Chemie. Cornell University New York, USA Function of 3’,5’-cAMP in regulating the actin cytoskeleton in Arabidopsis . Dr. Aleksandra Skirycz . Boyce Thompson Institute (BTI)

Structural biology of host-pathogen interactions Dr. Thomas Reubold Institute for Biophysical Chemistry, OE4350 Hannover Medical School Carl-Neuberg-Straße 1 30625 Hannover Office: Building I4, Floor S0 [...] and protein complexes from human pathogens. We seek to understand how these proteins contribute to the establishment of manifest disease as well as to identify drug targets for the development of novel [...] antimicrobial therapies. We use X-ray crystallography as primary technique for structure determination as well as a wide array of biochemical and biophysical methods to complement our structural studies

Keck J, Stripecke R. “In Vivo Lentiviral Gene Delivery of HLA-DR and Vaccination of Humanized Mice for Improving the Human T and B Cell Immune Reconstitution” Biomedicines . 2021 Aug 5;9(8):961. doi: 10. [...] Lachmann N , Cornu TI, Mussolino C, Schäfer R, Cathomen T. “CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells” Int J Mol Sci. 2024 Jan 12;25(2):985. doi: [...] Lachmann N , Verboom M, Frieling H, Hallensleben M, Martin U. An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the

genetisch modifizierter humaner pluripotenter Stammzellen Durch Verwendung „maßgeschneiderter“ Designernukleasen ist eine deutlich effizientere zielgerichtete genetische Modifikation humaner iPS-Zellen möglich [...] haben Wissenschaftler des LEBAOs nun zusammen mit Wissenschaftlern der Institute für experimentelle Hämatologie und für Humangenetik der MHH, sowie mit weiteren Kooperationspartnern des Universitätsklinikums [...] Efficient designer nuclease-based homologous recombination enables direct PCR screening for footprintless targeted human pluripotent stem cells. Stem Cell Reports 2, no. 1:107

martin@mh-hannover.de Supervisor: Prof. Dr. Hildegard Büning, Institute of Experimental Haematology, OE 6960 Project:AAV vector based approaches for immunotherapy of cancer. Final exam November 2022. Janin [...] Janin Bublitz GERMANY Supervisor: Prof. Dr. Doris Steinemann, Institute of Human Genetics, OE 6300 Project: Nachweis und Bedeutung von strukturellen Genom-Varianten beim familiären Brustkrebs (Detection and [...] systemic and pulmonary human immune response after allergic, inflammatory and infectious provocation. Final exam November 2021 . Ci Chu CHINA Supervisor: Prof. Dr. Dietmar Manstein, Institute of Biophysical Chemistry

Germany for doctoral studies. Junior Research Fellowship Preise by CSIR (Center for Scientific and Industrial Research)- NET (National Eligibility Test), India. GATE (Graduate Aptitude Test for Engineering) [...] Germany Prof. Dr. Christian Bär Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Germany Lehre Praktika für Medizinstudierende (Humanmedizin und Zahnämedizin) Seminare [...] ubiqitin „got the power” 2017: Projektleiter der Chromatin- und SUMO-Physiologie-Arbeitsgruppe, Institut für Molekular- und Zellphysiologie, Medizinische Hochschule Hannover. 2011 - 2017: Postdoktorand

Requirements for Pharmaceuticals for Human Use (ICH) seit 01/2007 Deutscher Vertreter in der Scientific Advice Working Party (SAWP) des Committee for Medicinal Products for Human Use (CHMP) 04/2015 - 11/2017 [...] Europäischer Experte in der "Drafting Group for ICH-E17" des International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) 10/2010 - 10/2018 Mitglied und (ab [...] Beirats des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG) 09/2009 – 09/2018 Mitglied der Biostatistics Working Party (BSWP) des Committee for Medicinal Products for Human Use (CHMP)